South Korea
Onconic Therapeutics, a leading biotechnology company in Korea, announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQB...
April 26, 2024 | News
The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...
April 26, 2024 | News
Recorded Q1'24 consolidated revenue of KRW 946.9 billion Recorded Q1'24 consolidated operating profit of KRW 221.3 billion Sustained growth d...
April 25, 2024 | News
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesit...
April 24, 2024 | News
OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding (MOU) with SillaJen, a Kosdaq-listed biotech ...
April 23, 2024 | News
Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative...
April 23, 2024 | News
Hyundai Bioscience CEO Oh Sang-gi, announced its plan to launch global clinical trials for a revolutionary treatment targeting all four serotypes of ...
April 22, 2024 | News
CryptoLab, a pioneer of fully homomorphic encryption (FHE) technology has announced the signing of a three-year supply contract with Macrogen, Korea'...
April 18, 2024 | News
The Republic of Korea is emerging as a global leader in the life science space, as a result of strong public sector support and private sector investments....
April 04, 2024 | News
In an illuminating interview with BioPharma APAC, Sebastian Arana, Executive Vice President and Global Head of Process Solutions at Merck, shares insights ...
April 02, 2024 | Interview
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announ...
April 01, 2024 | News
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, ...
March 29, 2024 | News
Johnson & Johnson Innovation – JLABS (JLABS) will activate its global network to enhance the competitiveness of Korean biotech and medtech startu...
March 29, 2024 | News
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a...
March 27, 2024 | News
Most Read
Bio Jobs
News
Editor Picks